Happy Thanksgiving! Save 50% on Your MarketBeat All Access Subscription.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Walmart shooter left 'death note,' bought gun day of killing
See how to make money instead of spending it on Black Friday with this offer (Ad)
MarketBeat: Week in Review 11/21 - 11/25
See the World with Dollar Flight Club's Lowest Price for Black Friday Weekend
See how to make money instead of spending it on Black Friday with this offer (Ad)
Arrival, Coupa Software rise; Apple, Activision fall
Inflation hovers over shoppers seeking deals on Black Friday
THE BEST BLACK FRIDAY DEAL YET (Ad)
Mexico's domestic airline industry in shambles
Macao awards casino licenses to MGM, Sands, Wynn, 3 others
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Walmart shooter left 'death note,' bought gun day of killing
See how to make money instead of spending it on Black Friday with this offer (Ad)
MarketBeat: Week in Review 11/21 - 11/25
See the World with Dollar Flight Club's Lowest Price for Black Friday Weekend
See how to make money instead of spending it on Black Friday with this offer (Ad)
Arrival, Coupa Software rise; Apple, Activision fall
Inflation hovers over shoppers seeking deals on Black Friday
THE BEST BLACK FRIDAY DEAL YET (Ad)
Mexico's domestic airline industry in shambles
Macao awards casino licenses to MGM, Sands, Wynn, 3 others
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Walmart shooter left 'death note,' bought gun day of killing
See how to make money instead of spending it on Black Friday with this offer (Ad)
MarketBeat: Week in Review 11/21 - 11/25
See the World with Dollar Flight Club's Lowest Price for Black Friday Weekend
See how to make money instead of spending it on Black Friday with this offer (Ad)
Arrival, Coupa Software rise; Apple, Activision fall
Inflation hovers over shoppers seeking deals on Black Friday
THE BEST BLACK FRIDAY DEAL YET (Ad)
Mexico's domestic airline industry in shambles
Macao awards casino licenses to MGM, Sands, Wynn, 3 others
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Walmart shooter left 'death note,' bought gun day of killing
See how to make money instead of spending it on Black Friday with this offer (Ad)
MarketBeat: Week in Review 11/21 - 11/25
See the World with Dollar Flight Club's Lowest Price for Black Friday Weekend
See how to make money instead of spending it on Black Friday with this offer (Ad)
Arrival, Coupa Software rise; Apple, Activision fall
Inflation hovers over shoppers seeking deals on Black Friday
THE BEST BLACK FRIDAY DEAL YET (Ad)
Mexico's domestic airline industry in shambles
Macao awards casino licenses to MGM, Sands, Wynn, 3 others

Genprex - GNPX Price Target & Analyst Ratings

$1.29
-0.03 (-2.27%)
(As of 11/25/2022 04:00 PM ET)
Add
Compare
Today's Range
$1.29
$1.32
50-Day Range
$1.27
$1.58
52-Week Range
$1.17
$3.62
Volume
11,310 shs
Average Volume
66,673 shs
Market Capitalization
$61.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Genprex Consensus Rating and Price Target (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

N/A
Based on 0 Analyst Ratings

Consensus Analyst Price Target

N/A

TypeCurrent
11/26/21 to 11/26/22
1 Month Ago
10/27/21 to 10/27/22
3 Months Ago
8/28/21 to 8/28/22
1 Year Ago
11/26/20 to 11/26/21
Consensus RatingN/AN/AN/A
Buy
Strong Buy N/A N/A N/A
0 Strong Buy rating(s)
Buy N/A N/A N/A
1 Buy rating(s)
Hold N/A N/A N/A
0 Hold rating(s)
Sell N/A N/A N/A
0 Sell rating(s)
Consensus Price TargetN/AN/AN/A$7.00
Predicted UpsideN/AN/AN/A65.09% Upside
Get Genprex Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for GNPX and its competitors with MarketBeat's FREE daily newsletter.


GNPX Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

GNPX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Genprex Stock vs. The Competition

TypeGenprexMedical CompaniesS&P 500
Consensus Rating Score
0.00
2.66
2.48
Consensus RatingN/ABuyHold
Predicted Upside761.80% Upside12.74% Upside
News Sentiment RatingVery Positive News
Positive News
Neutral News
MarketBeat
Community Rating
Outperform Votes
195
64.78%
Underperform Votes
106
35.22%
Avg. Outperform Votes
164
66.40%
Avg. Underperform Votes
83
33.60%
Avg. Outperform Votes
853
68.19%
Avg. Underperform Votes
398
31.81%

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
1/26/2021National Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$7.00+65.09%
5/26/2020Noble Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Cosme Ordonez
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$5.00+79.21%
4/22/2020Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy
(Data available from 11/26/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












GNPX Price Target - Frequently Asked Questions

Do MarketBeat users like Genprex more than its competitors?

MarketBeat users like Genprex less than other Medical companies. 64.78% of MarketBeat users gave Genprex an outperform vote while medical companies recieve an average of 66.40% outperform votes by MarketBeat users.


Stock Ratings Reports and Tools

This page (NASDAQ:GNPX) was last updated on 11/26/2022 by MarketBeat.com Staff